STOCK TITAN

Harrow (HROW) CCO Patrick Sullivan receives 40,000 performance and time-based RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Harrow, Inc.’s chief commercial officer, Patrick William Sullivan, received two new restricted stock unit awards. On 01/30/2026 he was granted 25,000 RSUs and 15,000 RSUs under the company’s 2025 Incentive and Awards Plan, each RSU representing one share of Harrow common stock upon vesting.

The 25,000 RSUs have a five-year term and vest only if Harrow’s revenue reaches $230,000,000 in a single calendar quarterly period, tying this award directly to a significant revenue milestone. The 15,000 RSUs will vest in full three years after the grant date, on 01/30/2029, providing longer-term equity-based compensation. Both awards are held directly by Sullivan.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sullivan Patrick William

(Last) (First) (Middle)
C/O HARROW, INC.
1A BURTON HILLS BLVD., SUITE 200

(Street)
NASHVILLE TN 37215

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HARROW, INC. [ HROW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF COMMERCIAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
RSU(1) $0 01/30/2026 A 25,000 (1) (1) Common Stock 25,000 $0 25,000 D
RSU(2) $0 01/30/2026 A 15,000 (2) (2) Common Stock 15,000 $0 15,000 D
Explanation of Responses:
1. Represents restricted stock units ("RSU's) granted under the Issuers 2025 Incentive and Awards Plan, (the "Plan"). Each RSU represents a right to receive one share of common stock of the Issuer upon vesting. The RSU's have a five-year term and vest when Harrow's revenue reaches $230,000,000 in a calendar quarterly period.
2. Represents RSUs granted under the Plan. Each RSU represents a right to receive one share of common stock of the Issuer upon vesting. The RSU's will vest in full after 3 years from the date of the award on 1/30/2029.
/s/ Andrew R. Boll as Attorney in Fact for Patrick Sullivan 02/02/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Harrow (HROW) grant to its chief commercial officer?

Harrow granted Patrick William Sullivan two restricted stock unit awards on 01/30/2026: 25,000 RSUs and 15,000 RSUs. Each RSU represents the right to receive one share of Harrow common stock upon vesting, under the company’s 2025 Incentive and Awards Plan.

What performance condition applies to Patrick Sullivan’s 25,000 Harrow (HROW) RSUs?

The 25,000 RSUs vest only when Harrow’s revenue reaches $230,000,000 in a single calendar quarterly period. They have a five-year term, so vesting depends on the company achieving that specific revenue milestone within the award’s term.

When do Patrick Sullivan’s 15,000 Harrow (HROW) RSUs vest?

The 15,000 RSUs granted to Patrick Sullivan vest in full three years after the award date, on 01/30/2029. Once vested, each RSU converts into one share of Harrow common stock, subject to the plan’s standard terms and conditions.

How many Harrow (HROW) RSUs does Patrick Sullivan beneficially own after these grants?

After the reported transactions, Patrick Sullivan beneficially owns 25,000 RSUs from the performance-based award and 15,000 RSUs from the time-based award. Both positions are reported as directly held derivative securities tied to Harrow common stock.

Under which plan were Patrick Sullivan’s Harrow (HROW) RSUs granted?

Both RSU awards were granted under Harrow’s 2025 Incentive and Awards Plan. The plan provides equity-based compensation, with each restricted stock unit representing a right to receive one share of Harrow common stock when the relevant vesting conditions are satisfied.
Harrow Health Inc

NASDAQ:HROW

HROW Rankings

HROW Latest News

HROW Latest SEC Filings

HROW Stock Data

1.75B
31.08M
15.72%
57.42%
13.38%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
NASHVILLE